Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 15 April 2005:
Vol. 308. no. 5720, pp. 345 - 346
DOI: 10.1126/science.308.5720.345
Prev | Table of Contents | Next

News Focus

ADDICTION RESEARCH:
Ibogaine Therapy: A 'Vast, Uncontrolled Experiment'

Brian Vastag

Despite potentially harsh side effects, an African plant extract is being tested in two public clinical trials--and many clandestine ones.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Long-QT Syndrome Induced by the Antiaddiction Drug Ibogaine.
D. W.M. Hoelen, W. Spiering, and G. D. Valk (2009)
N. Engl. J. Med. 360, 308-309
   Full Text »    PDF »
Ibogaine, a Noncompetitive Inhibitor of Serotonin Transport, Acts by Stabilizing the Cytoplasm-facing State of the Transporter.
M. T. Jacobs, Y.-W. Zhang, S. D. Campbell, and G. Rudnick (2007)
J. Biol. Chem. 282, 29441-29447
   Abstract »    Full Text »    PDF »
Author's reply.
U. Werneke (2006)
The British Journal of Psychiatry 188, 587-588
   Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)